Curanex, botanical drug developer, files for $10M IPO

Oct. 17, 2024 3:58 PM ETRenaissance IPO ETF (IPO)By: Val Brickates Kennedy, SA News Editor
(<1min)
IPO and stock growth graph

mapo

  • Curanex Pharmaceuticals (CURX) has filed for a proposed $10M initial public offering.
  • According to an SEC filing, Curanex is looking to offer 2M shares priced between $4 and $6 per share, which would raise $10M if priced at the midpoint. The company is hoping to

Recommended For You

More Trending News

About IPO ETF

SymbolLast Price% Chg
Expense Ratio
Div Frequency
Div Rate
Yield
Assets (AUM)
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IPO--
Renaissance IPO ETF